Axq Capital »

Entrada Therapeutics shares owned by Axq Capital

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Axq Capital from 13F filings

Historical chart of Axq Capital investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Axq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Axq Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $67k 12k 5.80

More positions owned by Axq Capital

Dover Corporation (DOV)
Arista Networks Com Shs (ANET)
Vistra Energy (VST)
Palantir Technologies Cl A (PLTR)
3M Company (MMM)
Honeywell International (HON)
Bristol Myers Squibb (BMY)
Amphenol Corp Cl A (APH)
Godaddy Cl A (GDDY)
EOG Resources (EOG)
Interactive Brokers Group In Com Cl A (IBKR)
Prudential Financial (PRU)
Gilead Sciences (GILD)
Cardinal Health (CAH)
Huntsman Corporation (HUN)

View all positions for Axq Capital

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
Renaissance Technologies
TCG Crossover Management
State Street Corporation
Dimensional Fund Advisors
Royce & Associates
Citadel Advisors

View all funds holding Entrada Therapeutics